Scholars Central

Conference abstractPublished 2019

Glucose Toxicity: The worldwide problem and the all-natural solution

Authors: John F. Burd

Lysulin Inc., USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Glucose toxicity is an epidemic problem leading to the insulin resistance and the development of obesity, prediabetes and Type 2 diabetes in both children and adults. In addition to poor health and early death, this is costing our healthcare systems a fortune to treat diabetes and its complications. Glucose is not a passive bystander in our bloodstream but is a toxic and reactive compound. Glucose reacts with all of the proteins in our body forming GLYCATED PROTEINS. These glycated proteins progress to become what is known as ADVANCED GLYCATION ENDPRODUCTS or AGEs. These AGEs are known to be the culprits in the disease complications associated with diabetes including kidney failure, blindness, amputations and cardiovascular disease. Protein glycation is also be the cause of insulin resistance. Insulin resistance not only leads to high blood glucose levels in our bloodstream, but also leads to insulin depletion. When this happens, we may have to resort to injection of insulin in an attempt to keep our blood glucose levels in the normal range. There is now an all-natural solution to the glucose toxicity problem. In over 20 years of R&D and clinical studies, nutritional supplements have been proven to combat glucose toxicity. Three important supplements having this ability are the LYSINE, ZINC and VITAMIN C. Combining these three important supplements into one tablet makes a powerful weapon to combat glucose toxicity and protein glycation. This weapon is Lysulin®. Unlike the available prescription drugs for type 2 diabetes which are directed at the symptoms of diabetes (high blood glucose), Lysulin is the first product directed at the problem, which is glucose toxicity and protein glycation. Clinical studies have proven that Lysulin lowers HbA1c better than the vast majority of prescription drugs. Current therapy for type 2 diabetes and the history of studies proving the effectiveness of Lysulin will be presented along with recent data from double blind placebo controlled studies with Lysulin.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Endocrinology & Diabetes Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalEndocrinology & Diabetes Research
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “John F. Burd”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels